Skip to main content

Table 2 Patient samples used for sequencing and MALDI TOF

From: The composition and functional protein subsystems of the human nasal microbiome in granulomatosis with polyangiitis: a pilot study

Samples Total aGPA inGPA DC HC HHC Longitudinal
V1 V2 16Sa 59 7 31 2 7 4 (3 patients) 8 (7 patients)
Shotgun sequenced 96 12 43 13 11 5 (4 patients) 12 (11 patients)
MALDI-TOF 83 10 36 12 0 3 9
Cultured S. aureus 32 8 15 3 2 1 2
Cultured S. warneri 15 1 4 5 2 1 2
Cultured S. pasteuri 3 0 3 0 0 0 0
Cultured S. capitis 11 1 5 3 2 0 0
Cultured S. epidermidis 13 0 7 1 3 1 1
Cultured S. pseudintermedius 4 0 2 0 0 0 2 (1 patient)
Cultured S. haemolyticus 17 0 8 4 2 1 2
Cultured S. caprae 1 1 0 0 0 0 0
Cultured S. saphrophyticus 1 0 1 0 0 0 0
Cultured S. lugdunensis 2 0 1 0 1 0 0
Cultured S. simulans 1 0 0 1 0 0 0
Cultured S. pettenkoferi 1 0 0 0 1 0 0
  1. Abbreviations: aGPA active granulomatosis with polyangiitis, inGPA inactive GPA, DC disease controls (microscopic polyangiitis and eosinophilic GPA), HC healthy controls, HHC healthy household controls, MALDI-TOF matrix-assisted laser desorption/ionisation–time-of-flight mass spectrometry
  2. aFor the bacterial 16S rRNA sequencing project, we sequenced the bacterial 16S rRNA variable region v1 and v2